Drug Shortage Report for DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC

Last updated on 2020-03-24 History
Report ID 107152
Drug Identification Number 02329743
Brand name DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC
Common or Proper name Sodium Iodide 131 I
Company Name JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Market Status MARKETED
Active Ingredient(s) SODIUM IODIDE 131 I
Strength(s) 7400MBq
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 Capsule/Vial
ATC code V10XA
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-02-24
Estimated end date 2020-03-23
Actual end date 2020-03-23
Shortage status Resolved
Updated date 2020-03-24
Company comments A product component procured from a 3rd party did not meet JDI’s specifications.
Health Canada comments
Tier 3 Status No
Contact Address 16751 TRANS CANADA HWY
KIRKLAND, QUEBEC
CANADA H9H 4J4
Company contact information Hiba Soulaihi HSoulaihi@jubl.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-03-24 English Compare
v10 2020-03-23 French Compare
v9 2020-03-23 English Compare
v8 2020-03-23 French Compare
v7 2020-03-23 English Compare
v6 2020-03-09 French Compare
v5 2020-03-09 English Compare
v4 2020-03-02 French Compare
v3 2020-03-02 English Compare
v2 2020-02-25 French Compare
v1 2020-02-25 English Compare

Showing 1 to 11 of 11